Bookimed does not add extra charges for Pancreatic cancer treatment prices. The rates come from the clinics' official price lists. You pay directly at the clinic for your treatment upon your arrival to the country.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Pancreatic cancer treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Pancreatic cancer treatment journey.
The cost of pancreatic cancer treatment can range from $12,030 to $28,090:
The doctor will determine the total treatment cost based on your needs and past treatments. You may not need to redo previous tests, which could save money.
| The USA | Turkey | Mexico | |
| Whipple surgery | from $40000 | from $19000 | from $21850 |
| Tomotherapy | from $30000 | from $10000 | from $11500 |
| Pancreatic cancer surgery | from $25500 | from $8500 | from $4900 |
| NanoKnife | from $9000 | from $3000 | from $3450 |
Ospedale San Raffaele (San Raffaele Research Hospital) in Milan is one of the largest research hospitals in Europe. It applies ad hoc methods for rare immune system and genetic diseases treatment.
Among its achievements — the world's first stem cell therapy for patients with severe combined immune deficiency disorder (ADA-SCID).
Oncology, oncohematology, neurosurgery, neurology, cardiovascular surgery, urology, and gynecology are the strongest specialities here.
Surgeons of the hospital perform over 52,000 operations annually.
Policlinico San Donato is a leading Italian clinic for cardiology and cardiac surgery.
Doctors perform over 9,400 open and minimally invasive operations on the heart and blood vessels annually. It is the largest number in the country.
Сardiology, heart surgery, arrhythmology, and rehabilitation are the top specialities in San Donato Hospital.
Located in Oblia (Sardinia), Mater Olbia Hospital is an international center of excellence, created by combining the skills and the respective experiences of Qatar Foundation Endowment and Fondazione Policlinico Universitario Agostino Gemelli IRCCS in Rome.
The Mater Olbia Hospital is a preferred destination for patients from around the world, in search of top-level expertise, cutting-edge technology and modern and luxurious premises.
Professor Massimo Falconi is a gastrointestinal oncologist with over 30 years of experience specializing in pancreatic diseases. He practices at Ospedale San Raffaele in Milan and has led 3,600 surgeries, including distal, total, middle pancreatectomies , pancreatic resections, and enucleations. He is the Director of the Pancreatic Surgery and the Pancreas Translational and Clinical Unit at IRCCS Ospedale San Raffaele with international experience in Japan, Spain, Germany, and Sweden. Prof. Falconi has written over 330 articles and taken part in 350+ Italian and 220+ international conferences, and is a member of several organizations.
Director of the General Surgery Unit at Mater Olbia Hospital with Medical Degree with Honors from Catholic University, Rome, Italy and Certificate of Specialist in General Surgery. Experienced in performing over 1300 surgical procedures including liver, pancreas, and kidney transplants and 500 cases of oncologic operations. Teaching activity at School of Medicine and Surgery, Cattolica International, Università Cattolica del Sacro Cuore, Rome, Italy. Member of Italian Society of Surgery and the Italian Society of Oncologic Surgery. Author and co-author of publications in international journals.
Professor Michele Reni is an experienced medical oncologist with over 30 years of practice based in Italy. He specializes in pancreatic adenocarcinoma, gastro-esophageal cancers, and central nervous system tumors. He has published over 180 papers on cancer treatment and is the coordinator of Italian Association of Medical Oncology (AIOM) guidelines for treatment and management of pancreatic cancer. He has also chaired numerous clinical trials on treating patients with metastatic pancreatic cancer.